Clinical Trial: Sodium-Glucose Cotransporter-2 Inhibitor for Acute Cardiorenal Syndrome: A Feasibility Study
Study Status: NOT_YET_RECRUITING
Recruit Status: NOT_YET_RECRUITING
Condition: Cardiorenal Syndrome
Study Type: INTERVENTIONAL
Official Title: Sodium-Glucose Cotransporter-2 Inhibitor for Acute Cardiorenal Syndrome: A Feasibility Study
Brief Summary:
The overall objective of this study is to determine whether the addition of SGLT2 inhibitors to usual care during acute heart failure shortens the time to symptomatic improvement and kidney function recovery.The study aims to assess feasibility, acceptability, and impact on decongestion and early biomarkers of kidney injury.
Read more